Details of the Drug
General Information of Drug (ID: DM6QU5B)
| Drug Name |
1-phenyl-3-(1,3,4-thiadiazol-2-yl)thiourea
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
1-phenyl-3-(1,3,4-thiadiazol-2-yl)thiourea; CHEMBL1253381; AC1LHWR1; SCHEMBL13779380; MolPort-002-153-004; ZINC436272; BDBM50326573; AKOS000986880; MCULE-5997854144; SDCCGMLS-0064737.P001; ST50980881; AB00086777-01; SR-01000210707; SR-01000210707-1; Z56753795; (phenylamino)(1,3,4-thiadiazol-2-ylamino)methane-1-thione
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 236.3 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 1.9 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


